Tuesday, November 22, 2011

Significant Upside to Dendreon Stock in a Buyout

›
Acquiring Dendreon (DNDN-$7.50) offers a better-capitalized pharmaceutical company an opportunity to buy control of a potential blockbuster...
1 comment:
Thursday, November 17, 2011

Is "The Sky Falling" at Dendreon?

›
Dendreon’s (DNDN-$7.50) balance sheet shows the strain of what happens when it takes 15 years to bring a novel, first-in-class cancer treat...
Friday, November 04, 2011

MF Global Stakeholders Trusted Corzine, Lose Everything

›
Highly leveraged, with limited liquidity, MF Global was unable to meet margin calls or the demands from regulators to boost capital reserve...
3 comments:
Monday, October 31, 2011

Ben & Jerry's: Out to Serve and Protect?

›
Unilever (UL-$34.16) has remained reticent as senior management of wholly-owned Ben & Jerry’s announced “deep admiration” for those pr...
Sunday, October 23, 2011

Overstating Peak Production in Utica Shale?

›
Chesapeake Energy (CHK-$27.81) is accelerating drilling on liquids-rich plays in an effort to drive margin expansion and profitability, giv...
1 comment:
Monday, October 10, 2011

Billions in Federal Aid for No Job Creation at First Solar and SunPower

›
SunPower (SPWRA-$8.45) and First Solar (FSLR-$59.78) boast that recently approved utility-scale projects will nourish growth of manufactur...
2 comments:
Friday, September 30, 2011

Ralcorp Board's Merger Rejection Doesn't Hold Milk

›
St. Louis-based Ralcorp (RAH-$77.00) has repeatedly spurned buyout offers from ConAgra , opining it could best unlock shareholder value by ...
Monday, September 19, 2011

Donut Holes in Dunkin Brands' Books

›
The asset side of Dunkin’ Brands’ (DNKN-$26.86) balance sheet is bloated, with 55% of total assets, or $1.7 billion, nothing more than inta...
Sunday, September 11, 2011

Ground Zero: In Flanders Fields Remembered

›
In Flanders fields the poppies blow Between the crosses, row on row, That mark our place; and in the sky The larks, still bravely singing, f...
Wednesday, September 07, 2011

The More Fashions Change at Talbots....

›
In yet another reboot, actress Julianne Moore, 51, will be the new face of yet another splashy ad campaign over at The Talbots Inc (TLB-$2....
Sunday, August 28, 2011

Is Gold Fields Ltd Mining Fools Gold?

›
Though Gold Fields (GFI-$16.28) has a diverse global growth pipeline, with four major projects in resource development, plans to grow annua...
Friday, August 19, 2011

Falling Prices Nuke Recovery at ReneSola

›
Lower feed-in-tariffs in European markets are masking economic realities pressuring margins at ReneSola (SOL-$3.39) . Exacerbating a demand-...
Friday, August 12, 2011

Blockbuster's New Return Policy: Surviving

›
In a recent interview with the LA Times, Dish Network’s (DISH-$22.72) chief executive Joe Clayton articulated that the $320 million purc...
1 comment:
Monday, August 08, 2011

Dividend Payout Hang-Up Expected at Frontier Communications

›
Frontier Communications (FTR-$6.76) paid a total of $186.6 million in cash dividends in the second quarter, which amounted to an outflow of...
1 comment:
Friday, July 29, 2011

Investors Roast on Earnings at Green Mountain Coffee - Ignore Future Threats

›
Shares in Green Mountain Coffee Roasters (GMCR-$102.57) soared more than 16 percent, or $14.46, as investors responded enthusiastically to ...
Tuesday, July 26, 2011

10Q Detective Partners with 24/7 Wall St.

›
In our continuing effort to offer our readers relevant and timely information from the best and brightest pundits on stock investing, the 10...
1 comment:
Monday, June 20, 2011

Cancer Not Biggest Problem for Takeda's Actos

›
More evidence suggests a disproportionately greater risk of bladder cancer from Takeda Pharmaceuticals ’ Actos than with other oral diabeti...
Tuesday, April 26, 2011

Can Skecher Shape-up Toning Shoe Sales?

›
To Skecher USA’s (SKX-$20.50) credit, the shoe manufacturer recognized the willingness of American consumers (mostly women) to purchase foo...
2 comments:
Monday, March 21, 2011

No Growth Meltdown at Uranium Miner Cameco

›
PR problems from the Japanese disaster, nuclear plant phase-out programs in several European countries, and failure of global economic accor...
1 comment:
Friday, March 18, 2011

InterMune's Esbriet: Hype or Miracle Drug?

›
InterMune’s (ITMN -$44.00) internal forecasts for its new pulmonary fibrosis drug appear even more bullish than Wall Street, with managemen...
2 comments: